Dodge & Cox
- SEC CIK
- 0000200217
- Latest filing
- Aug 13, 2026
AZN holding history
AstraZeneca PLC in every 13F filed by Dodge & Cox, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AZN overviewAll 13F holders of AZNFull Q2 2026 holdings
- Shares (Q2 2026)
- 55,949
- Value
- $10.6M
- % of portfolio
- <0.1%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 55,949 | $10.6M | <0.1% | −1,525−2.7% | Reduced | Holders |
| Q1 2026 | 57,474 | $11.3M | <0.1% | −3,048−5.0% | ReducedConverted for a 1-for-2 split | Holders |
| Q4 2025 | 121,043 | $11.1M | <0.1% | −16,445−12.0% | Reduced | Holders |
| Q3 2025 | 137,488 | $10.5M | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 137,488 | $9.61M | <0.1% | +1,348+1.0% | Added | Holders |
| Q1 2025 | 136,140 | $10.0M | <0.1% | −7,570−5.3% | Reduced | Holders |
| Q4 2024 | 143,710 | $9.42M | <0.1% | −5,325−3.6% | Reduced | Holders |
| Q3 2024 | 149,035 | $11.6M | <0.1% | −750−0.5% | Reduced | Holders |
| Q2 2024 | 149,785 | $11.7M | <0.1% | −5,500−3.5% | Reduced | Holders |
| Q1 2024 | 155,285 | $10.5M | <0.1% | −390−0.3% | Reduced | Holders |
| Q4 2023 | 155,675 | $10.5M | <0.1% | −1,650−1.0% | Reduced | Holders |
| Q3 2023 | 157,325 | $10.7M | <0.1% | −39,250−20.0% | Reduced | Holders |
| Q2 2023 | 196,575 | $14.1M | <0.1% | −26,850−12.0% | Reduced | Holders |
| Q1 2023 | 223,425 | $15.5M | <0.1% | −84,900−27.5% | Reduced | Holders |
| Q4 2022 | 308,325 | $20.9M | <0.1% | −78,040−20.2% | Reduced | Holders |
| Q3 2022 | 386,365 | $21.2M | <0.1% | −116,124−23.1% | Reduced | Holders |
| Q2 2022 | 502,489 | $33.2M | <0.1% | −304,337−37.7% | Reduced | Holders |
| Q1 2022 | 806,826 | $53.5M | <0.1% | −11,069−1.4% | Reduced | Holders |
| Q4 2021 | 817,895 | $47.6M | <0.1% | −25,970−3.1% | Reduced | Holders |
| Q3 2021 | 843,865 | $50.7M | <0.1% | −30,161−3.5% | Reduced | Holders |
| Q2 2021 | 874,026 | $52.4M | <0.1% | −16,250−1.8% | Reduced | Holders |
| Q1 2021 | 890,276 | $44.3M | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.